RE: Stubborn share price24 Jun 2020 12:09
Chrishar - As always we can only speculate but I think it is a fair assumption that they started the analysis of the COPD ASAP.
3-4weeks seems to be reasonable estimation for duration of analysis, but always keen to hear any expert opinions.
I doubt Synairgen will want to sit on the data for too long because the risk of a leak increases, but equally I am sure they will be talking to interested parties in advanced of releasing to the market. Those interested parties will be under NDA and effectively in a close period too.
If the company is above board and the partner/s they are talking too are worth their salt I wouldn't expect anything to leak until results are hours away.